宏利亞洲CEO:宏利人壽遷冊至港反映有信心香港持續鞏固全球金融中心地位
宏利亞洲總裁兼首席執行官Steve Finch表示,香港是亞洲板塊中業務最大貢獻的地區,集團目標至2027年,亞洲區核心收益佔整體50%。他又指集團是香港最大強積金計劃供應商,亦在多方面服務客戶,認為宏利金融-S(00945.HK)旗下宏利人壽保險遷冊至香港合乎邏輯,反映對本港繼續鞏固作為區內及全球金融中心地位的信心,亦反映出集團對本港的長期承諾。
他表示,保險業可在兩方面支持本港國際金融中心地位。他認為,本港人口老齡化,突顯市民對醫療保健需求,而保險業可滿足客戶有關需求。另外,本港預計將超越瑞士成為全球最大財富管理中心,認為保險業在支持全球高增值人士方面發揮作用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.